ENKAM PHARMACEUTICALS ApS: Financial statements 2014
CVR: 25812921
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,669,049 and a net result of DKK 2,812,225 compared with DKK -3,665,105 the year before. Equity in the 2014 report amounted to DKK -1,918,271.
- Gross Profit
- DKK 4,669,049
- Profit/Loss
- DKK 2,812,225
- Equity
- DKK -1,918,271
- Total Assets
- DKK 1,281,268
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.7 mio. | 2.8 mio. | -1.9 mio. | - |
| 2013 | - | -2.6 mio. | -3.7 mio. | -4.7 mio. | - |
| 2012 | - | -1.1 mio. | -2.5 mio. | -3.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ENKAM PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK -2,621,140, and the net result was DKK -3,665,105.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.